Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA: A Cancer. J Clin. 2023;73(3):233–54.

Google Scholar 

Galandiuk S, Wieand HS, Moertel CG, Cha SS, Fitzgibbons RJ Jr., Pemberton JH, et al. Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Surg Gynecol Obstet. 1992;174(1):27–32.

PubMed  CAS  Google Scholar 

Snyder RA, Hu C-Y, Cuddy A, Francescatti AB, Schumacher JR, Van Loon K, et al. Association between Intensity of Posttreatment Surveillance Testing and detection of recurrence in patients with Colorectal Cancer. JAMA. 2018;319(20):2104–15.

Article  PubMed  PubMed Central  Google Scholar 

Mant D, Gray A, Pugh S, Campbell H, George S, Fuller A, et al. A randomised controlled trial to assess the cost-effectiveness of intensive versus no scheduled follow-up in patients who have undergone resection for colorectal cancer with curative intent. Health Technol Assess (Winchester Eng). 2017;21(32):1–86.

Article  Google Scholar 

Pantel K, Speicher MR. The biology of circulating tumor cells. Oncogene. 2016;35(10):1216–24.

Article  PubMed  CAS  Google Scholar 

Smit DJ, Pantel K. Circulating tumor cells as liquid biopsy markers in cancer patients. Mol Aspects Med. 2024;96:101258.

Article  PubMed  CAS  Google Scholar 

Marcuello M, Vymetalkova V, Neves RPL, Duran-Sanchon S, Vedeld HM, Tham E, et al. Circulating biomarkers for early detection and clinical management of colorectal cancer. Mol Aspects Med. 2019;69:107–22.

Article  PubMed  CAS  Google Scholar 

Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, et al. Tumor cells circulate in the Peripheral blood of all Major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res. 2004;10(20):6897–904.

Article  PubMed  Google Scholar 

Neves RPL, Ammerlaan W, Andree KC, Bender S, Cayrefourcq L, Driemel C, et al. Proficiency testing to assess Technical Performance for CTC-Processing and Detection methods in CANCER-ID. Clin Chem. 2021;67(4):631–41.

Article  PubMed  Google Scholar 

Cohen SJ, Punt CJA, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, et al. Relationship of circulating Tumor cells to Tumor Response, Progression-Free Survival, and overall survival in patients with metastatic colorectal Cancer. J Clin Oncol. 2008;26(19):3213–21.

Article  PubMed  Google Scholar 

Riethdorf S, Fritsche H, Müller V, Rau T, Schindlbeck C, Rack B, et al. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Clin Cancer Res. 2007;13(3):920–8.

Article  PubMed  CAS  Google Scholar 

Hiraiwa K, Takeuchi H, Hasegawa H, Saikawa Y, Suda K, Ando T, et al. Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers. Ann Surg Oncol. 2008;15(11):3092–100.

Article  PubMed  Google Scholar 

Sato N, Hayashi N, Imamura Y, Tanaka Y, Kinoshita K, Kurashige J, et al. Usefulness of transcription-reverse transcription concerted reaction method for detecting circulating tumor cells in patients with colorectal cancer. Ann Surg Oncol. 2012;19(6):2060–5.

Article  PubMed  Google Scholar 

Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004;351(8):781–91.

Article  PubMed  CAS  Google Scholar 

Miller MC, Doyle GV, Terstappen LW. Significance of circulating Tumor cells detected by the CellSearch System in patients with metastatic breast colorectal and prostate Cancer. J Oncol. 2010;2010:617421. –Ab hier adaptieren.

Article  PubMed  Google Scholar 

Tol J, Koopman M, Miller MC, Tibbe A, Cats A, Creemers GJM, et al. Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents. Ann Oncol. 2010;21(5):1006–12.

Article  PubMed  CAS  Google Scholar 

Huang X, Gao P, Song Y, Sun J, Chen X, Zhao J, et al. Meta-analysis of the prognostic value of circulating tumor cells detected with the CellSearch System in colorectal cancer. BMC Cancer. 2015;15:202.

Article  PubMed  PubMed Central  Google Scholar 

Thorsteinsson M, Söletormos G, Jess P. Low number of detectable circulating tumor cells in non-metastatic colon cancer. Anticancer Res. 2011;31(2):613–7.

PubMed  Google Scholar 

Bork U, Rahbari NN, Schölch S, Reissfelder C, Kahlert C, Büchler MW, et al. Circulating tumour cells and outcome in non-metastatic colorectal cancer: a prospective study. Br J Cancer. 2015;112(8):1306–13.

Article  PubMed  PubMed Central  CAS  Google Scholar 

van Dalum G, Stam G-J, Scholten FAL, Mastboom JBW, Vermes I, Tibbe GJA, et al. Importance of circulating tumor cells in newly diagnosed colorectal cancer. Int J Oncol. 2015;46(3):1361–8.

Article  PubMed  Google Scholar 

Sotelo MJ, Sastre J, Maestro ML, Veganzones S, Viéitez JM, Alonso V, et al. Role of circulating tumor cells as prognostic marker in resected stage III colorectal cancer. Annals Oncology: Official J Eur Soc Med Oncol. 2015;26(3):535–41.

Article  CAS  Google Scholar 

Abdalla TSA, Meiners J, Riethdorf S, König A, Melling N, Gorges T, et al. Prognostic value of preoperative circulating tumor cells counts in patients with UICC stage I-IV colorectal cancer. PLoS ONE. 2021;16(6):e0252897–e.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Rahbari NN, Bork U, Kircher A, Nimitz T, Schölch S, Kahlert C, et al. Compartmental Differences of Circulating Tumor Cells in Colorectal Cancer. Ann Surg Oncol. 2012;19(7):2195–202.

Article  PubMed  Google Scholar 

Rahbari NN, Bork U, Schölch S, Reissfelder C, Thorlund K, Betzler A, et al. Metastatic spread emerging from liver metastases of Colorectal Cancer. Ann Surg. 2016;263(2):345–52.

Article  PubMed  Google Scholar 

Denève E, Riethdorf S, Ramos J, Nocca D, Coffy A, Daurès J-P, et al. Capture of viable circulating tumor cells in the liver of Colorectal Cancer patients. Clin Chem. 2013;59(9):1384–92.

Article  PubMed  Google Scholar 

Zhao J-X, Liu L-R, Yang X-Y, Liu F, Zhang Z-G. Serum CA19-9 as a marker of circulating tumor cells in first reflux blood of colorectal cancer patients. Oncotarget. 2017;8(40):67918–32.

Article  PubMed  PubMed Central  Google Scholar 

Connor AA, McNamara K, Al-Sukhni E, Diskin J, Chan D, Ash C, et al. Central, but not peripheral, circulating Tumor cells are prognostic in patients undergoing resection of Colorectal Cancer Liver metastases. Ann Surg Oncol. 2016;23(7):2168–75.

Article  PubMed  Google Scholar 

Jiao LR, Apostolopoulos C, Jacob J, Szydlo R, Johnson N, Tsim N, et al. Unique Localization of Circulating Tumor Cells in patients with hepatic metastases. J Clin Oncol. 2009;27(36):6160–5.

Article  PubMed  Google Scholar 

Kaifi JT, Kunkel M, Das A, Harouaka RA, Dicker DT, Li G, et al. Circulating tumor cell isolation during resection of colorectal cancer lung and liver metastases: a prospective trial with different detection techniques. Cancer Biol Ther. 2015;16(5):699–708.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Le UT, Bronsert P, Picardo F, Riethdorf S, Haager B, Rylski B, et al. Intraoperative detection of circulating tumor cells in pulmonary venous blood during metastasectomy for colorectal lung metastases. Sci Rep. 2018;8(1):8751.

Article  PubMed  PubMed Central  Google Scholar 

Zeune L, van Dalum G, Terstappen LWMM, van Gils SA, Brune C. Multiscale Segmentation via Bregman Distances and nonlinear spectral analysis. SIAM J Imaging Sci. 2017;10(1):111–46.

Article  Google Scholar 

Zeune LL, de Wit S, Berghuis AMS, Ijzerman MJ, Terstappen LWMM, Brune C. How to agree on a CTC: evaluating the Consensus in circulating Tumor Cell Scoring. Cytometry Part A. 2018;93(12):1202–6.

Article  Google Scholar 

Coumans FAW, Doggen CJM, Attard G, de Bono JS, Terstappen LWMM. All circulating EpCAM + CK + CD45- objects predict overall survival in castration-resistant prostate cancer. Annals Oncology: Official J Eur Soc Med Oncol. 2010;21(9):1851–7.

Article  CAS